Virpax®Pharmaceuticals, Inc. announced that Gerald W. Bruce has been appointed as President and CEO of Novvae? Pharmaceuticals, Virpax?s wholly-owned subsidiary focused solely on advancing the Company?s OTC pipeline. Mr. Bruce has spent over 30 years in the pharmaceutical and medical nutrition industries.

Most recently, he served as a Vice President of sales for Danone Specialized Nutrition North America, Danone?s medical nutrition division. Prior to this position, he has held roles of increasing responsibility at Nitromed, Inc. and Bristol-Meyers Squibb. Mr. Bruce began his career at Johnson and Johnson and spent 13 years there starting as a sales representative and moving up the ranks to become a Group Marketing Director in Analgesics.

He has a BA from Lincoln University and an Executive Master?s Degree in Leadership from Georgetown University?s McDonough School of Business.